Clinical Trials Directory

Trials / Completed

CompletedNCT02195999

Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy

Status
Completed
Phase
Study type
Observational
Enrollment
9 (actual)
Sponsor
University of Florida · Academic / Other
Sex
Male
Age
5 Years – 15 Years
Healthy volunteers
Not accepted

Summary

This study seeks to develop and validate non-invasive assessments of cardiac and respiratory muscles with magnetic resonance imaging (MRI) to better predict the natural disease progression of Duchenne muscular dystrophy (DMD) in affected individuals over time, as well as determine whether peripheral skeletal muscle dysfunction can predict cardiopulmonary dysfunction. The central hypothesis is that non-invasive MRI measures of the heart, muscle, and peripheral skeletal muscles can sensitively predict future cardiopulmonary decline.

Detailed description

Magnetic Resonance Imaging (MRI) of the heart and breathing muscles, special breathing tests (called pulmonary function testing), special exercise tests (using a stationary bike), and possibly an echocardiogram (ultrasound of the heart, commonly known as an "echo") will be completed up to 4 times per year for up to 4 years. Most participants will complete testing once or twice each year; however, some participants will be asked to repeat some of the tests twice during each visit.

Conditions

Interventions

TypeNameDescription
OTHERMagnetic Resonance Imaging (MRI)It is a non-invasive method to determine ventricular size, volumes, mass, and ejection fraction.
OTHERPulmonary Function Testing (PFT)It is non-invasive breathing tests that characterize respiratory muscle function, as well as lung compliance and physiology.
OTHERMetabolic Exercise Testing using stationary bicycleMetabolic exercise testing, including assessment of exercise capacity and MVO2, evaluates global cardiopulmonary functional status. This is performed with the use of a stationary bicycle.
OTHEREchocardiogramThe echocardiogram performed with the multiple-echo Dixon method helps to assess participants cross-sectionally and longitudinally for variations and changes in myocardial structure.

Timeline

Start date
2013-12-01
Primary completion
2019-03-06
Completion
2019-03-06
First posted
2014-07-21
Last updated
2019-07-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02195999. Inclusion in this directory is not an endorsement.